Session 7 Antiplatelet And Fibrinolytic Drugs Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is a thrombus?

A

A clot adhered to vessel wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an embolus?

A

Intravascular clot distal to site of origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compare venous thrombosis and arterial thrombosis

What they are associated with

Fibrin content

Platelet content

Cells etc

A

VENOUS =

  • associated with stasis of blood and/or damage to the veins (less likely to see endothelial damage!)
  • HIGH RBC
  • HIGH fibrin content
  • LOW platelet content

ARTERIAL =

  • usually forms at side of atherosclerosis following plaque rupture
  • LOWER fibrin content
  • HIGH (much higher!) platelet content
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What substance that is released and produced by endothelial cells inhibits platelet aggregation?

A

Prostacyclin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does prostacyclin (PGI2) inhibit platelet aggregation?

A

It binds to platelet receptors which increases the concentration of cAMP in platelets

This is coupled with a decrease in platelet aggregatory agents

Stabilise (keeps inactive) GPIIb/IIIa receptors :)

NB: this occurs in healthy endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do antiplatelet and fibrinolytic drugs target?

A

Platelet rich “white” arterial thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do parenteral anticoagulants and heparins/warfarin etc target?

A

lower platelet content “red” venous thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give a name of a drug that is an example of a cyclo-oxygenase inhibitor

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is TXA2 formed and what is it? (Thromboxane A2 = TXA2)

A

TXA2 is a potent platelet aggregating agent

It is formed from arachidonic acid by COX-1
Aspirin inhibits this!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does aspirin work?

A

It inhibits the COX-1 mediated production of TXA2 (and so reduces platelet aggregation = IRREVERSIBLE!) - acetylation of CO

TXA2 is formed by COX1 and is a potent platelet aggregating agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are

Low doses of aspirin used for?

A

Low dosing = antiplatelet effects (75mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do higher doses of aspirin do?

A

Higher doses inhibit endothelial prostacyclin (PGI2)

- imbalance!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is aspirin absorbed?

A

Passive diffusion

Hepatic hydrolysis to salicylic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the warnings / side effects of Aspirin?

A
  • Bleeding time prolonged - Haemorrhagic stroke, GI bleeding (peptic ulcer)
  • Reye’s syndrome (avoid if under 16 y.o) - can occur after a viral infection - can be fatal
  • Hypersensitivity
  • 3rd trimester of pregnancy - aspirin can lead to early closure of the ductus arteriosus!

Need to take these things into account and weight up benefit vs risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Contradictions of Aspirin?

A

Other antiplatelet and anticoagulants (additive/synergistic actions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does inhibition (caused by aspirin) last lifespan of platelet? (7-10 days)

A

Lack nuclei so unable to produce more COX

17
Q

When would we use aspirin?

A
  • 2nd prevention of stroke, TIA, ACS, MI in stable or peripheral vascular disease
  • post primary percutaneous coronary intervention and stent to reduce ischaemic complications
  • loading dose in ACS - chewable! (300 mg)
18
Q

What are 3 drugs that are ADP receptor antagonists?

A

Clopidogrel

Prasugrel

Ticagrelor

19
Q

How do ADP receptor antagonists work?

Which ones are reversible or irreversible?

Which ones have slow onset of action and which ones have a fast onset of action?

A

They inhibit the binding f ADP to P2Y receptor SO inhibit the activation of GPIIb/IIIa receptors
(Independent of the COX pathway)

Clopidogrel and prasugrel are: irreversible inhibitors and prodrugs
Ticagrelor acts reversible at different site to clopidogrel

Clopidogrel has a slow onset of action without loading dose
But
Prasugrel and ticagrelor have more rapid onset

20
Q

Warnings / side effects of ADP receptor antagonists?

A

Bleeding! GI upset - dyspepsia and diarrhoea which can lead to thrombocytopenia

Caution - renal and hepatic impairment

21
Q

Contraindications of ADP receptor antagonists

A

Clopidogrel requires CYPs for activation (so think of the things that inhibit CYPs such as SSRI’s)

Ticagrelor can interact with CYP inhibitors and inducers

Caution when co prescribed with other antiplatelets and anticoagulants

22
Q

If someone is having surgery and is taking clopidogrel and/or ticagrelor, what do we do?

A

Stop clopidogrel 7 days prior to surgery

Stop Ticagrelor about 5 days prior to surgery

23
Q

Indications for ADP receptor antagonists?

A

Often used where aspirin is contraindicated in mono therapy

If someone has had a Non-STEMI (up to 12 months after)

If someone has has a STEMI and has a stent (up to 12 months after)

ACS patients (with aspirin)

Balance between CV events and bleeding risk

24
Q

Name of a glycoproteins IIb/IIIa inhibitor?

A

Abciximab

25
Q

How do glycoprotein IIb/IIIa inhibitors work?

Abciximab

A

Blocks binding of fibrinogen and vWF
(Targets final common pathway!)

The abciximab antibody blocks glycoprotein IIb/IIIa inhibitors
(>80% reduction in aggregation)

Given IV w/ bolus

26
Q

Warnings of abciximab (glycoprotein inhibitor)

A

Bleeding!!!!!!!

Dose needs to be adjusted for body weight

Thrombocytopenia, hypotension and bradycardia are also side effects

27
Q

Contradictions of glycoprotein inhibitors? (Abciximab)

A

Caution with other antiplatelet and anticoagulant agents

NB: specialist use in high risk percutaneous transluminal coronary angioplasty patients

28
Q

Name of a phosphodiesterase inhibitor?

A

Dipyridamole

29
Q

How do phosphodiesterase inhibitors work?

A

Inhibits cellular reputable of adenosine

This will increase plasma adenosine

Adenosine will inhibit platelet aggregation via A2 receptors

30
Q

Warnings / side effects of phosphodiesterase inhibitors?

A

Flushing, headache and hypersensitivity

31
Q

Contraindications of phosphodiesterase inhibitors?

A

Caution with antihypertensives, antiplatelets ad anticoagulants

32
Q

Uses of phosphodiesterase inhibitors?

A

Secondary prevention of ischaemic stroke and TIA’s

Adjunct for prophylaxis of thromboembolism following valve replacement

33
Q

What are some examples of fibrinoltic agents?

I.e. clot busters

A

Streptokinase

Alteplase

34
Q

Problems with streptokinase?

A

Can only be used once as antibodies develop

35
Q

What is tranexamic acid used for?

A

Slows the breakdown of clots

I.e. stops fibrin clot —> fibrin degradation products

36
Q

What are the downstream consequences of dipyridamole’s phosphodiesterase inhibiting action?

A

Prevents cAMP degradation so I hit s expression of GP IIb/IIIa